Value of FDA Accelerated Approval in Drug Development Ozmosi October 29, 2024 Meeting of the Pharmacy Compounding Advisory Committee The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York An appraisal of FDA approvals for adult solid tumours in 20172021: has the eagle landed? Nature Reviews Clinical Oncology